Oncotarget

Research Papers:

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway

Bahityar Rahmutulla, Kazuyuki Matsushita _, Mamoru Satoh, Masanori Seimiya, Sachio Tsuchida, Shuji Kubo, Hideaki Shimada, Masayuki Ohtsuka, Masaru Miyazaki and Fumio Nomura

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2014; 5:2404-2417. https://doi.org/10.18632/oncotarget.1650

Metrics: PDF 1424 views  |   HTML 1667 views  |   ?  


Abstract

Bahityar Rahmutulla1,4, Kazuyuki Matsushita1,2, Mamoru Satoh1,2, Masanori Seimiya1,2, Sachio Tsuchida1, Shuji Kubo5, Hideaki Shimada6, Masayuki Ohtsuka3, Masaru Miyazaki3, and Fumio Nomura1,2

1 Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba City, Chiba, Japan

2 Division of Laboratory Medicine, Chiba University Hospital, Chiba City, Chiba, Japan

3 Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba City, Chiba, Japan

4 Department of Orthopedics and Traumatology, Hospital of Uyghur Medicine, Urumqi, Sinkiang Uyghur Autonomous Region, P. R. China

5 Department of Genetics, Hyogo College of Medicine, Nishinomiya City, Nishinomiya, Hyogo Prefecture, Japan

6 Department of Gastroenterological Surgery, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan

Correspondence:

Kazuyuki Matsushita, email:

Keywords : FBP interacting repressor (FIR), bleomycin(BLM), DNA damage, Ku86, c-Myc, P27Kip1

Received: December 3, 2013 Accepted: December 21, 2013 Published: December 21, 2013

Abstract

The far-upstream element-binding protein-interacting repressor (FIR) is a c-myc transcriptional suppressor. FIR is alternatively spliced to lack the transcriptional repression domain within exon 2 (FIRΔexon2) in colorectal cancers. FIR and FIRΔexon2 form homo- or heterodimers that complex with SAP155. SAP155, a subunit of the essential splicing factor 3b subcomplex in the spliceosome, is required for proper P27Kip1 pre-mRNA splicing, and P27Kip1 arrests cells at G1. In contrast, FIR was co-immunoprecipitated with Ku86 and DNA-PKcs. siRNA against Ku86/Ku70 decreased FIR and P27Kip1 expression, whereas siRNA against FIR decreased Ku86/XRCC5 and P27Kip1 expression. Thus the mechanical interaction of FIR/FIRΔexon2/SAP155 bridges c-myc and P27Kip1 expression, potentially integrates cell-cycle progression and c-myc transcription in cell.

Bleomycin(BLM) is an anticancer agent that introduces DNA breaks. Because DNA breaks generate the recruitment of Ku86/Ku70 to bind to the broken DNA ends, the possible involvement of FIR and Ku86/Ku70 interaction in the BLM-induced DNA damage repair response was investigated in this study. First, BLM treatment reduced SAP155 expression and increased FIR and FIRΔexon2 mRNA expression as well as the ratio of FIRΔexon2:FIR in hepatoblastoma cells (HLE and HLF). Second, FIR or FIRΔexon2 adenovirus vectors (Ad-FIR or Ad-FIRΔexon2) increased Ku86/Ku70 and P27Kip1 expression in vitro. Third, BLM decreased P27Kip1 protein expression, whereas increased P27Kip1 and γH2AX expression with Ad-FIRΔexon2. Together, the interaction of FIR/SAP155 modulates FIR splicing and involves in cell-cycle control or cell fate via P27Kip1 and c-myc in BLM-induced DNA damage pathway. This novel function of FIR splicing will contribute to clinical studies of cancer management through elucidating the mechanical interaction of FIR/FIRΔexon2/SAP155 as a potential target for cancer treatment.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 1650